Viewing Study NCT06284902


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-20 @ 6:39 PM
Study NCT ID: NCT06284902
Status: COMPLETED
Last Update Posted: 2025-09-12
First Post: 2024-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioavailability Study of Fexofenadine HCl New Formulation Tablet
Sponsor: Opella Healthcare Group SAS, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module